HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M C Kurth Selected Research

CRA 2059

3/2002Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M C Kurth Research Topics

Disease

1Ulcerative Colitis
03/2002
1Alzheimer Disease (Alzheimer's Disease)
01/2001
1Parkinsonian Disorders (Parkinsonism)
03/2000

Drug/Important Bio-Agent (IBA)

1Tryptases (Tryptase)IBA
03/2002
1CRA 2059IBA
03/2002
1Pharmaceutical PreparationsIBA
01/2001
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
03/2000
1Levodopa (L Dopa)FDA LinkGeneric
03/2000
1Tolcapone (Tasmar)FDA Link
03/2000